|
시장보고서
상품코드
2091211
프로게스테론 시장 규모, 점유율, 성장 분석 : 제제별, 투여 경로별, 용도별, 약물 유형별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Progesterone Market Size, Share, and Growth Analysis, By Formulation, By Route of Administration, By Application, By Drug Type, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 프로게스테론 시장 규모는 2024년에 16억 3,000만 달러로 평가되었으며, 2025년 18억 4,000만 달러에서 2033년까지 47억 9,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 12.74%로 성장할 것으로 전망됩니다.
세계 프로게스테론 시장은 불임증과 호르몬 장애의 증가를 배경으로 눈부신 발전을 이루고 있습니다. 의료진이 기존의 산과적 용도를 넘어 적용 범위를 확대함에 따라, 경구용 초미세 분말 프로게스테론 제제 및 주사용 프로게스테론 제제에 대한 수요가 급증하고 있습니다. 갱년기 호르몬 대체요법과 보조생식기술 역시 시장 성장을 더욱 뒷받침하고 있습니다. 미국은 여전히 주요 수익원이나, 신흥 시장, 특히 인도에서는 불임 치료에 대한 인식이 높아짐에 따라 현저한 성장이 나타나고 있습니다. 규제 측면의 진전에 따라 피하 투여 제제나 서방형 임플란트 제제와 같은 혁신적인 투여 방법이 도입되면서, 환자의 복약 순응도가 향상되고 있습니다. 보험사의 지원 덕분에 이용 가능한 치료 옵션이 확대되고, 제약사와 생명공학 기업 간의 경피 패치 개발을 위한 협력이 촉진됨에 따라, 그 결과 성숙 시장과 신흥 시장 모두에서 성장 가능성이 열리고 있습니다.
세계 프로게스테론 시장의 성장요인
프로게스테론에 대한 수요 증가는 불임 치료 이용 확대에 크게 영향을 받고 있습니다. 이는 프로게스테론이 황체기의 유지와 임신 초기의 안정화에 있어 매우 중요한 역할을 하기 때문입니다. 이로 인해, 특히 보조생식술 주기나 자연 임신을 원하는 사람들을 대상으로 한 처방량이 급증하고 있습니다. 의료진은 착상 성공률을 높이기 위해 프로게스테론에 의존하고 있으며, 불임 치료를 받는 환자들 사이에서 그 사용이 점점 더 널리 받아들여지고 있습니다. 이러한 의존도의 증가는 시장 규모를 확대할 뿐만 아니라 신제품 및 투여 시스템의 개발을 촉진하며, 그 결과 제형의 최적화와 환자의 복약 순응도 향상을 위한 연구 개발에 대한 지속적인 투자를 뒷받침하고 있습니다.
세계 프로게스테론 시장의 제약요인
세계 프로게스테론 시장은 시장 성장을 저해하는 엄격한 규제 승인 절차로 인해 큰 제약에 직면해 있습니다. 이러한 엄격한 요건으로 인해 개발 기간이 길어지며, 각 제제의 안전성과 유효성에 관한 종합적인 문서화가 필요합니다. 각 제약사는 복잡한 임상시험 설계에 대응하고, 다양한 투여 방식에서 일관된 생체이용률을 입증해야 한다는 과제에 직면해 있으며, 그 결과 제품 출시가 지연되고 있습니다. 이러한 엄격한 규정 준수에 주력하는 것은 혁신을 위한 자원을 할당하는 결과를 초래하며, 종종 중소기업의 시장 진입을 가로막는 요인이 되고 있습니다. 그 결과, 규제 요건의 강화가 시장 역학을 저해하여 소비자가 이용할 수 있는 치료 선택의 폭을 좁히고 있습니다.
세계 프로게스테론 시장의 동향
세계 프로게스테론 시장은 부인과 분야 건강 솔루션에 대한 수요가 증가하는 것을 배경으로, 뚜렷한 상승세를 보이고 있습니다. 월경 장애, 불임, 갱년기 증상의 발생률이 높아짐에 따라, 의료 종사자들은 천연 치료법으로서 프로게스테론을 점점 더 중요하게 여기고 있습니다. 천연 호르몬 균형을 우선시하는 이러한 추세는, 생체 동일 호르몬의 이점을 강조하는 환자 교육 활동을 통해 더욱 뒷받침되고 있으며, 환자와 의료 제공자 모두의 수용도가 높아지고 있습니다. 그 결과, 경구용 및 주사용 프로게스테론 제제 시장이 확대되고 있으며, 전 세계의 기존 시장과 신흥 시장 모두에서 견조한 성장이 예상됩니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 프로게스테론 시장 규모 : 제제별
세계의 프로게스테론 시장 규모 : 투여 경로별
세계의 프로게스테론 시장 규모 : 용도별
세계의 프로게스테론 시장 규모 : 약물 유형별
세계의 프로게스테론 시장 규모 : 유통 채널별
세계의 프로게스테론 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.07.22Global Progesterone Market size was valued at USD 1.63 Billion in 2024 and is poised to grow from USD 1.84 Billion in 2025 to USD 4.79 Billion by 2033, growing at a CAGR of 12.74% during the forecast period (2026-2033).
The global progesterone market has evolved significantly, propelled by rising infertility rates and hormonal disorders. Demand for oral micronized and injectable progesterone formulations has surged as practitioners expand beyond traditional obstetric applications. Menopausal hormone replacement therapies and assisted reproductive technologies have further catalyzed market growth. The U.S. remains a key revenue contributor, while emerging markets, particularly India, are experiencing notable expansion due to heightened awareness of fertility treatments. Regulatory advancements have paved the way for innovative delivery methods, such as subcutaneous and sustained-release implant formulations, enhancing patient adherence. The support from insurance providers has broadened accessible treatment options, fostering collaboration between pharmaceutical manufacturers and biotech firms in developing transdermal patches, thereby unlocking growth potential in both established and developing markets.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Progesterone market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Progesterone Market Segments Analysis
Global progesterone market is segmented by formulation, route of administration, application, drug type, distribution channel and region. Based on formulation, the market is segmented into Natural Progesterone and Synthetic Progestins. Based on route of administration, the market is segmented into Injectables, Oral, Topical/Vaginal and Transdermal. Based on application, the market is segmented into Menopause Management, Fertility Treatment / IVF, Endometriosis, Abnormal Uterine Bleeding and Preterm Birth Prevention. Based on drug type, the market is segmented into Branded and Generic. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Progesterone Market
The increasing demand for progesterone is significantly influenced by the growing utilization of fertility treatments, as it plays a crucial role in supporting the luteal phase and maintaining early pregnancy. This has led to a surge in prescription volumes, particularly within assisted reproductive technology cycles and for those seeking natural conception support. Healthcare professionals depend on progesterone to enhance implantation success rates, driving a wider acceptance among patients looking for fertility solutions. This increased dependence not only broadens the market's reach but also encourages the development of new products and delivery systems, thereby promoting ongoing investment in research to optimize dosage forms and improve patient adherence.
Restraints in the Global Progesterone Market
The global progesterone market faces significant restraints due to stringent regulatory approval processes that impede market growth. These stringent requirements lead to extended development timelines and necessitate comprehensive documentation of safety and efficacy for each formulation. Manufacturers are challenged by the need to navigate complex clinical trial designs and demonstrate consistent bioavailability across various delivery methods, resulting in delayed product launches. This rigorous compliance focus diverts resources away from innovation, often discouraging smaller companies from entering the market. As a result, the increased regulatory demands hinder market dynamics and limit the range of therapeutic options available to consumers.
Market Trends of the Global Progesterone Market
The global progesterone market is witnessing a significant upward trend driven by an increasing demand for gynecological health solutions. As the incidence of menstrual disorders, infertility, and menopausal symptoms rises, healthcare professionals are increasingly favoring progesterone as a natural therapeutic option. This shift towards prioritizing natural hormone balance is further bolstered by patient education initiatives that promote the advantages of bioidentical hormones, leading to greater acceptance among patients and providers alike. As a result, there is a growing market for both oral and injectable progesterone formulations, with robust expansion anticipated in both established and emerging regions worldwide.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Progesterone Market Size by Formulation & CAGR (2026-2033)
- Market Overview
- Natural Progesterone
- Synthetic Progestins
Global Progesterone Market Size by Route of Administration & CAGR (2026-2033)
- Market Overview
- Injectables
- Oral
- Topical/Vaginal
- Transdermal
Global Progesterone Market Size by Application & CAGR (2026-2033)
- Market Overview
- Menopause Management
- Fertility Treatment / IVF
- Endometriosis
- Abnormal Uterine Bleeding
- Preterm Birth Prevention
Global Progesterone Market Size by Drug Type & CAGR (2026-2033)
- Market Overview
- Branded
- Generic
Global Progesterone Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Progesterone Market Size & CAGR (2026-2033)
- North America (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
- US
- Canada
- Europe (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- IBSA Farmaceutici
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Besins Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ferring Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co. Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orion Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sun Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Watson Pharmaceuticals (Allergan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Actavis (AbbVie)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ANI Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Laboratoire Theramex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CooperSurgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Organon & Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medicis Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Athenex Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AMCO-PHOS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ivagen Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
